Johnson & Johnson has claimed FDA approval for Rybrevant Faspro, a subcutaneous version of its EGFRxMET bispecific antibody, for all the indications approved for the current, intravenous formulation.
Dehydration happens when you lose more fluids than you take in. In older adults, it can raise the risk of constipation, electrolyte imbalances, kidney problems, and falls. Older adults are more prone ...